Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patientsSaroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidenceSaroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.Quantitative determination of saroglitazar, a predominantly PPAR alpha agonist, in human plasma by a LC-MS/MS method utilizing electrospray ionization in a positive mode.Pharmacokinetics, safety, and tolerability of saroglitazar (ZYH1), a predominantly PPARα agonist with moderate PPARγ agonist activity in healthy human subjects.Saroglitazar for the treatment of dyslipidemia in diabetic patients.From 'Make in India' to 'Made in India': the saroglitazar story.The first approved agent in the Glitazar's Class: Saroglitazar
P921
Q34469183-48ACA50E-9064-43F4-A901-29F388297F16Q35492306-22468168-1E6E-4396-BA5B-EF2C36E005E9Q35822331-9E4C1FBA-EA6C-44E5-BC5A-5EC0FCB96812Q36019949-706FA7FC-F388-43CF-9C13-0D3D8DDBB764Q37298699-C67279BE-9DF4-4A84-8FC1-4367F2BA438AQ38352759-9BCF2733-8014-4B23-8605-12EADC6186DDQ42559674-A6B54504-2161-4A6C-8B40-074441676EEBQ87180082-E3B0CFB0-C98B-4D18-9A1F-A887E8DBC39B
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Saroglitazar
@sh
Saroglitazar
@sr
saroglitazar
@en
type
label
Saroglitazar
@sh
Saroglitazar
@sr
saroglitazar
@en
prefLabel
Saroglitazar
@sh
Saroglitazar
@sr
saroglitazar
@en
P6366
P661
P662
P683
P2017
CCO[C@@H](CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O
P2067
P231
495399-09-2
P233
CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O
P234
1S/C25H29NO4S/c1-4-29-24(25(27 ...... 7H2,1-3H3,(H,27,28)/t24-/m0/s1
P235
MRWFZSLZNUJVQW-DEOSSOPVSA-N
P274
C₂₅H₂₉NO₄S
P3117
DTXSID10197819
P373
Saroglitazar
P6366
2779704027
P652
E0YMX3S4JD